Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $15.0B |
| Sales growthchange from the year before | +35.8% |
| Operating marginshare of sales left after running the business | 8.4% |
| Net marginshare of sales kept as profit | 10.3% |
| Return on invested capitalprofit made on each $100 put into the business | 2.0% |
| Return on equityprofit vs. shareholders' accounting value | 4.2% |
| Debt / equitydebt vs. shareholders' accounting value | 0.37 |
| Interest coverhow many times profit covers interest payments | 5.2x |
| Change in share countnegative = the company is buying back its shares | +35.4% |
1 insider sold $6.6M (all under pre-arranged plans) on the open market.
| Meloy Charles AlvinDirector | Sold (plan)Aug 3 | 33,333 shat $198.41 · $6.6M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy